175 related articles for article (PubMed ID: 11783102)
21. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.
Yanagi T; Mizoe JE; Hasegawa A; Takagi R; Bessho H; Onda T; Kamada T; Okamoto Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):15-20. PubMed ID: 19046826
[TBL] [Abstract][Full Text] [Related]
22. [Primary malignant melanoma of the cervix: report of four cases and review of the literature].
Ma SQ; Bai CM; Yu XH; An YT; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):183-5. PubMed ID: 15840314
[TBL] [Abstract][Full Text] [Related]
23. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
24. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
McCluggage WG; Bissonnette JP; Young RH
Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
[TBL] [Abstract][Full Text] [Related]
25. [Malignant melanoma of nasal cavity: report of 24 cases].
Chen M; Lin Z; Tang X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):246-7. PubMed ID: 8745469
[TBL] [Abstract][Full Text] [Related]
26. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
27. Malignant melanoma of the mucous membranes of the head and neck: three case reports.
Dass A; Virk RS; Hundal H; Mohan H
Ear Nose Throat J; 2006 Apr; 85(4):268-70. PubMed ID: 16696363
[TBL] [Abstract][Full Text] [Related]
28. Spindle cell rhabdomyosarcoma in adults.
Nascimento AF; Fletcher CD
Am J Surg Pathol; 2005 Aug; 29(8):1106-13. PubMed ID: 16006807
[TBL] [Abstract][Full Text] [Related]
29. [Management of lymph nodes in head and neck melanoma: a retrospective study of 25 cases].
Ricard AS; Majoufre-Lefebvre C; Delaunay M; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):505-8. PubMed ID: 17900640
[TBL] [Abstract][Full Text] [Related]
30. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
31. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
Leong SP; Accortt NA; Essner R; Ross M; Gershenwald JE; Pockaj B; Hoekstra HJ; Garberoglio C; White RL; Chu D; Biel M; Charney K; Wanebo H; Avisar E; Vetto J; Soong SJ;
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):370-3. PubMed ID: 16618904
[TBL] [Abstract][Full Text] [Related]
32. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma of nasal cavity: report of 16 Japanese patients.
Nakaya M; Mochiki M; Takeuchi S; Yuge T; Nakao K; Nakamura N; Sugasawa M
Auris Nasus Larynx; 2004 Sep; 31(3):233-7. PubMed ID: 15364357
[TBL] [Abstract][Full Text] [Related]
34. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
35. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
36. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer.
Leach BC; Kulbersh JS; Day TA; Cook J
Dermatol Surg; 2008 Apr; 34(4):483-97. PubMed ID: 18248467
[TBL] [Abstract][Full Text] [Related]
37. Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area.
Korabiowska M; Brinck U; Hoenig JF; Bartkowski SB; Kellner S; Marx D; Schauer A
Anticancer Res; 1995; 15(3):885-9. PubMed ID: 7645976
[TBL] [Abstract][Full Text] [Related]
38. [Surgical treatment possibilities of malignant melanomas in the head and neck region].
Kastenbauer ER
Laryngol Rhinol Otol (Stuttg); 1984 Jan; 63(1):3-8. PubMed ID: 6700331
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia.
Dunn GP; Lewis JS; Sunwoo JB; Uppaluri R
Head Neck; 2008 Feb; 30(2):267-72. PubMed ID: 17657794
[TBL] [Abstract][Full Text] [Related]
40. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan.
Wada H; Nemoto K; Ogawa Y; Hareyama M; Yoshida H; Takamura A; Ohmori K; Hamamoto Y; Sugita T; Saitoh M; Yamada S
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):495-500. PubMed ID: 15145168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
